Oncobiguanides: Paracelsus' law and nonconventional routes for administering diabetobiguanides for cancer treatment.
about
Phytochemicals modulate carcinogenic signaling pathways in breast and hormone-related cancersInhibiting stemness and invasive properties of glioblastoma tumorsphere by combined treatment with temozolomide and a newly designed biguanide (HL156A).Glipizide, an antidiabetic drug, suppresses tumor growth and metastasis by inhibiting angiogenesis.Mitochondrial DNA somatic mutation in cancerMetformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion currentMetformin-induced energy deficiency leads to the inhibition of lipogenesis in prostate cancer cells.High efficacy of intravesical treatment of metformin on bladder cancer in preclinical model.Impact of diabetes mellitus on risk of cardiovascular disease and all-cause mortality: Evidence on health outcomes and antidiabetic treatment in United States adultsGermline BRCA1 mutation reprograms breast epithelial cell metabolism towards mitochondrial-dependent biosynthesis: evidence for metformin-based "starvation" strategies in BRCA1 carriers.Nutrients in Energy and One-Carbon Metabolism: Learning from Metformin Users.Metformin and cancer: Quo vadis et cui bono?Chemokine ligand 2 and paraoxonase-1 in non-alcoholic fatty liver disease: The search for alternative causative factors.Synergistic effect of phenformin in non-small cell lung cancer (NSCLC) ionizing radiation treatment.Potential and real 'antineoplastic' and metabolic effect of metformin in diabetic and nondiabetic postmenopausal females.Metformin enhances TRAIL-induced apoptosis by Mcl-1 degradation via Mule in colorectal cancer cells.New metformin derivative HL156A prevents oral cancer progression by inhibiting the insulin-like growth factor/AKT/mammalian target of rapamycin pathways.Fatty acid synthase (FASN) as a therapeutic target in breast cancer.Antioxidant modifications induced by the new metformin derivative HL156A regulate metabolic reprogramming in SAMP1/kl (-/-) mice
P2860
Q26798324-108508A3-4BC8-4567-944C-98F6549D7946Q30353578-A89B642C-91B8-4808-A630-448632AEF7BBQ34654807-21B589BF-A494-464F-B442-B297BD043A21Q34906440-EBD8AA53-5826-4ABD-A5B3-3F08526621BEQ34957274-EF550A97-CC47-4A2B-98A2-FD8AD0E7D452Q36021086-680EB92F-11C9-411D-9635-68EC8AC8130AQ36962520-55DF4713-EAB3-4BD0-A10C-906960C67970Q37342041-E4B652A3-32FB-446C-9A72-D47547C53BD7Q37619695-27CC6B50-ACED-43CF-9128-0FF24BF938EBQ37673171-7E7D6986-3DD3-4DA5-AC0A-C15F5DF776FCQ37688014-4D553C1B-7A03-471E-A9C4-A58FD3DAC504Q38381079-85DB01A4-7A69-4A0E-B3E1-9215ABDF5ADFQ38948150-24A746C6-A43F-4B84-A91A-3E8C3A79C7B9Q39030844-BF0CE2BC-BAEE-4ACD-A22B-68F53B57931FQ42124995-13E5B462-D4B0-47AB-8E69-186ABEAB87AAQ47246957-9F2423A8-EBEE-430E-9729-96BBCAB596FFQ50044384-A9561905-73B5-4589-98D0-BFF62AAFE8AFQ58735442-3FFB4355-0B72-4DB6-A251-BC05BB0776E8
P2860
Oncobiguanides: Paracelsus' law and nonconventional routes for administering diabetobiguanides for cancer treatment.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Oncobiguanides: Paracelsus' la ...... guanides for cancer treatment.
@en
type
label
Oncobiguanides: Paracelsus' la ...... guanides for cancer treatment.
@en
prefLabel
Oncobiguanides: Paracelsus' la ...... guanides for cancer treatment.
@en
P2093
P2860
P356
P1433
P1476
Oncobiguanides: Paracelsus' la ...... guanides for cancer treatment.
@en
P2093
Antonio Segura-Carretero
Begoña Martin-Castillo
Bruna Corominas-Faja
Esther Rodríguez-Gallego
Javier A Menendez
Jorge Joven
Rosa Quirantes-Piné
Sílvia Cufí
P2860
P304
P356
10.18632/ONCOTARGET.1965
P407
P577
2014-05-01T00:00:00Z